Solutions

LVO stroke patient journey

The current stroke patient journey to treatment requires inter-hospital transfer for the various stages of stroke diagnosis. Using Pockit biomarkers with a handheld blood test, paramedics are able to identify LVO stroke cases on the spot and take them directly to a comprehensive stroke centre for treatment.


This time-saving difference would mean a 20% reduction in disabilities from LVO strokes.


Furthermore, every 10 minutes of earlier treatment leads to £8,172 of net monetary benefit, which leads to £3Bn saving in the US only, every year.

Clinical centres

we are looking for clinical centres interested in joining our clinical trials


https://clinicaltrials.gov/ct2/show/NCT04292600

Is your center interested in joining our trials?

Point of care companies

We look for companies focused in the development of technologies that can measure blood biomarkers at the point of care (POC).


If you are a diagnostics company and could be interested in partnering with us, we would like to hear from you.

Are you interested in a partnership with Pockit diagnostics?

Pockit investors

If you are an investor and would like to learn more about our next steps, please contact us.

Would you like to learn more about investment opportunities?

Contact us.